Skip to main content
. 2022 Jun 13;13:903565. doi: 10.3389/fneur.2022.903565

Figure 5.

Figure 5

Metformin, rapamycin, or NMN pretreatment alleviates microglial phagocytosis of myelin in the striatum after BCCAO. (A) Photomicrographs of triple immunofluorescent staining for Iba1 (red), CD68 (green), and MBP (blue). White arrows indicate Iba1+ microglia. Yellow arrows indicate Iba1+CD68+ microglia. Green arrows indicate Iba1+CD68+ MBP+ microglia. (B) Quantification of CD68 (green), Iba1 (red), and MBP (blue)-positive cells in the striatum of sham-operated and BCCAO rats pretreated with vehicle (Veh), metformin (Met), rapamycin (Rapa), or NMN (NMN) for 2 weeks before surgery. The p-values were assessed by the Kruskal–Wallis test with a Dunn post-test. All data were shown as mean ± SEM. N = 6 per group. 2VO, two-vessel occlusion.